Cargando…
Therapeutic plasma exchange: a second‐line treatment for brodifacoum poisoning following an anaphylactoid reaction to vitamin K
Vitamin K1 is the first‐line therapy to brodifacoum poisoning. Anaphylactoid reactions may occur anytime during intravenous administration of vitamin K1 injection. Vitamin K1 must be ceased when anaphylactoid reactions emerge, and therapeutic plasma exchange could be a second‐line option.
Autores principales: | Deng, Ying, Qiu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224774/ https://www.ncbi.nlm.nih.gov/pubmed/28096987 http://dx.doi.org/10.1002/ccr3.756 |
Ejemplares similares
-
Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy
por: Nosal, Daniel G., et al.
Publicado: (2021) -
The Severe Adverse Reaction to Vitamin K(1) Injection Is Anaphylactoid Reaction but Not Anaphylaxis
por: Mi, Yan-Ni, et al.
Publicado: (2014) -
Oral administration of injectable vitamin K1 in brodifacoum intoxication
por: Chu, Yen-Jung, et al.
Publicado: (2022) -
Disseminated Intravascular Coagulopathy Secondary to Unintentional Brodifacoum Poisoning via Synthetic Marijuana
por: Chan, Abigail, et al.
Publicado: (2019) -
Notes from the Field: Coagulopathy Associated with Brodifacoum Poisoning — Florida, December 2021
por: Coble, Nikki, et al.
Publicado: (2022)